We'll be re-adding old news archives to our News page over the next few days, so please keep a lookout if you're interested.
Hello.
This is Jellow.
This week's newsletter will be directed by me.
Before Corporate Restructuring:
New Upload on the Zypharin Rhythm YouTube Channel
On 14 July:
Zypharin has uploaded a new entertainment video. You can check it out at https://www.youtube.com/watch?v=Ss1zdb6HOLY.
Unfortunately, due to licensing and copyright issues, the video is not expected to perform well, along with any of its accompanying short(s).
We hope you'll check it out.
Important update regarding the launch of Zypharin Entertainment Portal (http://zypharin.com)
On 20 July: Zypharin Group announced that the Zypharin Entertainment Portal (zypharin.com), which was supposed to launch in Q2/2026 under the company’s 2026 fiscal year, has been cancelled indefinitely for the time being.
You can view the news release here: https://corp.zypharin.com/news/general-newsletter/company-important-update-on-zypharin-entertainment-portal-zypharin-com
X Release: https://x.com/zypharincorp/status/2079079939610169429, but please note information on the post is now outdated.
From After Corporate Restructuring:
Corporate Announcement Notice - Company Restructuring from 21st July 2026
To further improve how we operate the company and how we manage our services, Zypharin Group will be undergoing a corporate restructuring from this date until end of July.
Services we offer may change over this time period.
You can view the full news release at the link above.
At the time of writing, (22 July 2026 9:00 PM SGT), the company's websites have been updated. Please allow up to 7 days for everything to be updated. Thank you.
Click here to view the PDF Version
Executive Layout from this date onwards can also be found on the now-updated website, but for your convenience, I'll also list it here.
Jellow Noxetus Old Title: Chairperson, Founder and Member of the Board New and Current Title from Today: Chairman and Founder, Member of the Board
Amelia Old Title: Chief Operating Officer, Zypharin Group New and Current Title: Vice-Chairman of Zypharin Group
Hashiro: Old Title: Social Media Manager New and Current Title: -
Pixxel: Old Title: Chief Financial Officer New and Current Title: No Change
Unfortunately, Hashiro will no longer work with us following a downsizing initiated a while back.
Some links that'll function from now on as a standard basis:
https://corp.zypharin.com/services - Services
https://corp.zypharin.com/contact - Zypharin Contact
https://corp.zypharin.com/news - News (Company News, Financial and Performance Results, Zypharin Direct Informations)
https://corp.zypharin.com/company - Company Information, Mission, History, Executive Layout, Group Companies Information, and more
https://corp.zypharin.com/careers - Collaboration opportunities page
https://corp.zypharin.com/finance - Access the IR Library and Schedule through this page.
The presentation materials from Q2 and Q3 of this fiscal year can be found at https://corp.zypharin.com/finance/ir-library.
Additionally, the IR schedule / calendar can be found at https://corp.zypharin.com/finance/ir-schedule.
The following websites have been updated.
http://zypharin.com/ (Now serves as a redirector to Zypharin Corp. Website)
https://corp.zypharin.com/ - Main Operations Website
http://research.zypharin.com/ - Zypharin R&D Operations Website
https://calephron.zypharin.com/ - Calephron Website (English)
Over the next few days, we'll also be working on upgrading some services under us. If you encounter downtime on our services, please wait a moment and try again later.
Other News
From News Releases:
Following the company restructuring, the following specific site-based services may no longer
be available:
Past Research Information on the R / D Website
Engagement Stand (Will be replaced with a new one soon.) on the main website
FAQ (Will be replaced with a new one soon.) on the main website
The Legacy Content Policy will also be removed due to an update in our management policy.
Customer Harassment Policy will be minorly revised, with an updated version to launch in the
future.
[This email was delivered through the ZYPHARIN NEXUS NETWORK.]
https://nexus.zypharin.com/pid=1002/
Zypharin Product Information Website: https://zypharin.com
Do not reply to this email. If you wish to contact us for any inquiry or feedback, please do so through https://corp.zypharin.com/contact, then select what kind of inquiry you have.
You can unsubscribe at any time by emailing us a request at hq@zypharin.com. We appreciate your patience and understanding.
© 2026 Zypharin Group Holdings Inc. All rights reserved. All trademarks are property of their respective owners in the US, SG and other countries.
You can follow our SNS account at https://x.com/zypharincorp for the latest news and updates on Zypharin's products and services.
Content in this email is sent on a customer-by-customer basis, so please keep any information confidential.